Don M. Hardison
CIK: 0001209588
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About HARDISON DON M
HARDISON DON M (SEC CIK 0001209588) files insider reports with the SEC as Director of MDxHealth SA (MDXH) and Director of Cytek Biosciences, Inc. (CTKB).
Signal8 holds 3 ownership filings by HARDISON DON M (1 Form 3, 2 Form 4), filed between Jun 9, 2025 and Jun 3, 2026. Those filings report 2 transactions, from Jun 5, 2025 to Jun 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on HARDISON DON M's filings is in HERSTAL.
Recent filings by HARDISON DON M
Other insiders filing for MDxHealth SA (MDXH)
- MVM Partners, LLC, Director
- Sollee Joseph
- OConnell Brendan, VP, Finance and Accounting
- McGarrity Michael, Chief Executive Officer
- Windels Hilde, Director
- Bellano John, Chief Commercial Officer